Journal of Periodontal and Implant Science

Korean Academy of Periodontology (대한치주과학회)
권호 표지
DOI QR코드

DOI QR Code

Effects of scaling and root planing with or without a local drug delivery system on the gingival crevicular fluid leptin level in chronic periodontitis patients: a clinico-biochemical study

  • Received : 2014.02.17
  • Accepted : 2014.03.31
  • Published : 2014.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: The present split mouth study evaluates the effect of nonsurgical periodontal treatment on the gingival crevicular fluid (GCF) leptin level in chronic periodontitis. Methods: Ninety sites from 30 nonobese chronic periodontitis patients were selected and divided as follows: group I, 30 healthy sites receiving no treatment; group II, 30 periodontitis sites receiving scaling and root planing (SRP); and group III, 30 periodontitis sites receiving SRP with tetracycline local drug delivery. At baseline, after GCF sampling and clinical parameter recording, the assigned treatment was performed for the study groups. During recall visits, GCF sampling followed by clinical parameter recording was done for groups II and III. Results: Reductions in the probing depth and the clinical attachment level (CAL) were highly significant at different time intervals (except between day 0 and 45) in both groups II and III. Upon comparison, group III showed significant gain in CAL between day 0 and 15 and between day 0 and 45. After treatment, the reduction in the GCF leptin level was more significant in group III than in group II at day 15 but re-elevated almost to the pretreatment levels at day 45. Conclusions: Nonsurgical periodontal therapies were not effective in maintaining stable reduction in the GCF leptin level during the study period.

Keywords

References

  1. Hugoson A, Sjodin B, Norderyd O. Trends over 30 years, 1973-2003, in the prevalence and severity of periodontal disease. J Clin Periodontol 2008;35:405-14. https://doi.org/10.1111/j.1600-051X.2008.01225.x
  2. Genco RJ. Host responses in periodontal diseases: current concepts. J Periodontol 1992;63(4 Suppl):338-55. https://doi.org/10.1902/jop.1992.63.4s.338
  3. Mombelli A, Lehmann B, Tonetti M, Lang NP. Clinical response to local delivery of tetracycline in relation to overall and local periodontal conditions. J Clin Periodontol 1997;24:470-7. https://doi.org/10.1111/j.1600-051X.1997.tb00214.x
  4. Uitto VJ. Gingival crevice fluid: an introduction. Periodontol 2000 2003;31:9-11. https://doi.org/10.1034/j.1600-0757.2003.03101.x
  5. Johnson RB, Serio FG. Leptin within healthy and diseased human gingiva. J Periodontol 2001;72:1254-7. https://doi.org/10.1902/jop.2000.72.9.1254
  6. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature 1994;372:425-32. https://doi.org/10.1038/372425a0
  7. Matarese G, Moschos S, Mantzoros CS. Leptin in immunology. J Immunol 2005;174:3137-42. https://doi.org/10.4049/jimmunol.174.6.3137
  8. Range H, Poitou C, Boillot A, Ciangura C, Katsahian S, Lacorte JM, et al. Orosomucoid, a new biomarker in the association between obesity and periodontitis. PLoS One 2013;8:e57645. https://doi.org/10.1371/journal.pone.0057645
  9. Karthikeyan BV, Pradeep AR. Leptin levels in gingival crevicular fluid in periodontal health and disease. J Periodontal Res 2007;42:300-4. https://doi.org/10.1111/j.1600-0765.2006.00948.x
  10. Karthikeyan BV, Pradeep AR. Gingival crevicular fluid and serum leptin: their relationship to periodontal health and disease. J Clin Periodontol 2007;34:467-72. https://doi.org/10.1111/j.1600-051X.2007.01078.x
  11. Shimada Y, Komatsu Y, Ikezawa-Suzuki I, Tai H, Sugita N, Yoshie H. The effect of periodontal treatment on serum leptin, interleukin-6, and C-reactive protein. J Periodontol 2010;81:1118-23. https://doi.org/10.1902/jop.2010.090741
  12. Walker CB, Pappas JD, Tyler KZ, Cohen S, Gordon JM. Antibiotic susceptibilities of periodontal bacteria. In vitro susceptibilities to eight antimicrobial agents. J Periodontol 1985;56(11 Suppl):67-74. https://doi.org/10.1902/jop.1985.56.11s.67
  13. Goodson JM, Offenbacher S, Farr DH, Hogan PE. Periodontal disease treatment by local drug delivery. J Periodontol 1985;56:265-72. https://doi.org/10.1902/jop.1985.56.5.265
  14. Bjorvatn K, Skaug N, Selvig KA. Tetracycline-impregnated enamel and dentin: duration of antimicrobial capacity. Scand J Dent Res 1985;93:192-7.
  15. Morrison SL, Cobb CM, Kazakos GM, Killoy WJ. Root surface characteristics associated with subgingival placement of monolithic tetracycline-impregnated fibers. J Periodontol 1992;63:137-43. https://doi.org/10.1902/jop.1992.63.2.137
  16. Lesaffre E, Garcia Zattera MJ, Redmond C, Huber H, Needleman I; ISCB Subcommittee on Dentistry. Reported methodological quality of split-mouth studies. J Clin Periodontol 2007;34:756-61. https://doi.org/10.1111/j.1600-051X.2007.01118.x
  17. Silness J, Loe H. Periodontal disease in pregnancy. II. Correlation between oral hygiene and periodontal condtion. Acta Odontol Scand 1964;22:121-35. https://doi.org/10.3109/00016356408993968
  18. Loe H, Silness J. Periodontal disease in pregnancy. I. Prevalence and severity. Acta Odontol Scand 1963;21:533-51. https://doi.org/10.3109/00016356309011240
  19. Muhlemann HR, Son S. Gingival sulcus bleeding: a leading symptom in initial gingivitis. Helv Odontol Acta 1971;15:107-13.
  20. Ahima RS, Flier JS. Leptin. Annu Rev Physiol 2000;62:413-37. https://doi.org/10.1146/annurev.physiol.62.1.413
  21. Wauters M, Considine RV, Van Gaal LF. Human leptin: from an adipocyte hormone to an endocrine mediator. Eur J Endocrinol 2000;143:293-311. https://doi.org/10.1530/eje.0.1430293
  22. Chaffee BW, Weston SJ. Association between chronic periodontal disease and obesity: a systematic review and meta-analysis. J Periodontol 2010;81:1708-24. https://doi.org/10.1902/jop.2010.100321
  23. Suvan J, D'Aiuto F, Moles DR, Petrie A, Donos N. Association between overweight/obesity and periodontitis in adults: a systematic review. Obes Rev 2011;12:e381-404. https://doi.org/10.1111/j.1467-789X.2010.00808.x
  24. Bozkurt FY, Yetkin Ay Z, Sutcu R, Delibas N, Demirel R. Gingival crevicular fluid leptin levels in periodontitis patients with long-term and heavy smoking. J Periodontol 2006;77:634-40. https://doi.org/10.1902/jop.2006.050277
  25. Saito T, Yamaguchi N, Shimazaki Y, Hayashida H, Yonemoto K, Doi Y, et al. Serum levels of resistin and adiponectin in women with periodontitis: the Hisayama study. J Dent Res 2008;87:319-22. https://doi.org/10.1177/154405910808700416
  26. Slots J, Rams TE. Antibiotics in periodontal therapy: advantages and disadvantages. J Clin Periodontol 1990;17(7 Pt 2):479-93. https://doi.org/10.1111/j.1365-2710.1992.tb01220.x
  27. Rams TE, Keyes PH. A rationale for the management of periodontal diseases: effects of tetracycline on subgingival bacteria. J Am Dent Assoc 1983;107:37-41. https://doi.org/10.14219/jada.archive.1983.0177
  28. Baker PJ, Evans RT, Coburn RA, Genco RJ. Tetracycline and its derivatives strongly bind to and are released from the tooth surface in active form. J Periodontol 1983;54:580-5. https://doi.org/10.1902/jop.1983.54.10.580
  29. Garrett S, Johnson L, Drisko CH, Adams DF, Bandt C, Beiswanger B, et al. Two multi-center studies evaluating locally delivered doxycycline hyclate, placebo control, oral hygiene, and scaling and root planing in the treatment of periodontitis. J Periodontol 1999; 70:490-503. https://doi.org/10.1902/jop.1999.70.5.490
  30. Polson AM, Garrett S, Stoller NH, Bandt CL, Hanes PJ, Killoy WJ, et al. Multi-center comparative evaluation of subgingivally delivered sanguinarine and doxycycline in the treatment of periodontitis. II. Clinical results. J Periodontol 1997;68:119-26. https://doi.org/10.1902/jop.1997.68.2.119
  31. Drisko CL, Cobb CM, Killoy WJ, Michalowicz BS, Pihlstrom BL, Lowenguth RA, et al. Evaluation of periodontal treatments using controlled-release tetracycline fibers: clinical response. J Periodontol 1995;66:692-9. https://doi.org/10.1902/jop.1995.66.8.692
  32. Friesen LR, Williams KB, Krause LS, Killoy WJ. Controlled local delivery of tetracycline with polymer strips in the treatment of periodontitis. J Periodontol 2002;73:13-9. https://doi.org/10.1902/jop.2002.73.1.13
  33. Heijl L, Dahlen G, Sundin Y, Wenander A, Goodson JM. A 4-quadrant comparative study of periodontal treatment using tetracycline-containing drug delivery fibers and scaling. J Clin Periodontol 1991;18:111-6. https://doi.org/10.1111/j.1600-051X.1991.tb01699.x
  34. Eckles TA, Reinhardt RA, Dyer JK, Tussing GJ, Szydlowski WM, DuBous LM. Intracrevicular application of tetracycline in white petrolatum for the treatment of periodontal disease. J Clin Periodontol 1990;17(7 Pt 1):454-62. https://doi.org/10.1111/j.1600-051X.1990.tb02344.x
  35. Goodson JM, Holborow D, Dunn RL, Hogan P, Dunham S. Monolithic tetracycline-containing fibers for controlled delivery to periodontal pockets. J Periodontol 1983;54:575-9. https://doi.org/10.1902/jop.1983.54.10.575
  36. Tonetti MS, Pini-Prato G, Cortellini P. Principles and clinical applications of periodontal controlled drug delivery with tetracycline fibers. Int J Periodontics Restorative Dent 1994;14:421-35.
  37. Sorensen T, Echwald S, Holm JC. Leptin in obesity. BMJ 1996;313: 953-4. https://doi.org/10.1136/bmj.313.7063.953
  38. Ge H, Huang L, Pourbahrami T, Li C. Generation of soluble leptin receptor by ectodomain shedding of membrane-spanning receptors in vitro and in vivo. J Biol Chem 2002;277:45898-903. https://doi.org/10.1074/jbc.M205825200
  39. Wlodarski K, Wlodarski P. Leptin as a modulator of osteogenesis. Ortop Traumatol Rehabil 2009;11:1-6.
  40. Ducy P, Amling M, Takeda S, Priemel M, Schilling AF, Beil FT, et al. Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell 2000;100:197-207. https://doi.org/10.1016/S0092-8674(00)81558-5

Cited by

  1. Influence of obesity on the outcome of non-surgical periodontal therapy - a systematic review vol.16, pp.None, 2014, https://doi.org/10.1186/s12903-016-0272-2
  2. Effect of non‐surgical periodontal treatment on gingival crevicular fluid and serum leptin levels in periodontally healthy chronic periodontitis and chronic periodontitis patients with type 2 d vol.10, pp.3, 2014, https://doi.org/10.1111/jicd.12420
  3. Quantitative Assessment of Gingival Inflammation in Patients Undergoing Nonsurgical Periodontal Therapy Using Photometric CIELab Analysis vol.2021, pp.None, 2021, https://doi.org/10.1155/2021/6615603